Dengue Shock Management: Case-Based Learning for Doctors

Dengue Shock Management: Case-Based Learnings for Physicians

Introduction

Dengue remains one of the most significant vector-borne threats to India's healthcare system, with hundreds of thousands of cases reported across states every monsoon and post-monsoon season. While the majority of dengue infections resolve without complication, a small proportion of patients progress to dengue shock syndrome, a condition where plasma leakage leads to circulatory collapse if not identified and managed promptly. For physicians working in general wards, emergency departments, and even well-resourced tertiary centres, the difference between a good outcome and a fatal one frequently comes down to how quickly warning signs are recognised and how carefully fluid therapy is titrated.

This article draws on decades of accumulated clinical experience and structured training outcomes from dengue endemic regions to distil practical, case-level learnings for physicians managing dengue shock. The goal is not to repeat textbook definitions, but to walk through the clinical reasoning, common pitfalls, and evidence-based practices that separate confident management from delayed or excessive intervention. For Indian physicians, particularly those in tier two and tier three cities where laboratory turnaround and ICU access may be limited, these lessons carry direct relevance to daily practice.

Understanding Dengue Shock Syndrome

Dengue shock syndrome develops when the plasma leakage that characterises severe dengue becomes significant enough to compromise intravascular volume. Unlike many other causes of shock, the underlying pathology is not a failure of the heart or a loss of vascular tone in the classical sense, but a leakage of plasma out of the capillaries into surrounding tissues and body cavities. This leakage typically becomes clinically significant during what is called the critical phase, a period that begins around the time the fever starts to subside.

The transition from fever to defervescence can be deceptive. Family members and even junior physicians sometimes interpret the drop in temperature as a sign of recovery, when in fact this is often the point at which the patient requires the closest observation. Recognising this transition, and communicating its importance clearly to patients and their caregivers, is one of the most consistently cited lessons from experienced dengue treatment centres.

In India, the burden of dengue is substantial. The National Centre for Vector-Borne Diseases Control has documented significant year-on-year case counts, with several states including Kerala, Karnataka, Uttar Pradesh, and Delhi reporting sizeable outbreaks in recent years. Given this scale, the ability of frontline physicians to manage shock cases confidently has direct public health implications.

Primary Risk Factors for Progression to Shock

Not every dengue patient is at equal risk of progressing to shock. Certain factors consistently appear in cases that deteriorate.

Patients with secondary dengue infection, meaning they have been infected with a different dengue serotype previously, appear to carry a higher risk of severe disease due to immune mechanisms that are still being studied. Age also plays a role, with infants under one year, elderly patients, and pregnant women representing higher risk groups that warrant closer observation even in the absence of overt warning signs.

Co-existing conditions add further complexity. Patients with diabetes, hypertension, chronic kidney disease, chronic liver disease, or those on anticoagulant medication require individualised assessment, since their baseline physiology may mask or mimic warning signs of dengue progression. Obesity is another factor that clinicians are increasingly advised to account for, both because of altered fluid dynamics and because standard weight-based fluid calculations may need to reference ideal body weight rather than actual body weight.

Social and logistical factors matter as well, particularly in the Indian context. A patient living alone, residing far from a healthcare facility, or lacking reliable transportation may need to be admitted even with relatively mild warning signs, simply because the risk of delayed re-presentation is high.

Recognising the Warning Signs

The window between early warning signs and full-blown shock is often narrow, sometimes just a matter of hours. Physicians who have managed large volumes of dengue cases consistently emphasise a set of clinical indicators that should prompt immediate escalation of care.

Persistent vomiting, defined as three or more episodes within an hour or four or more episodes within six hours, is one of the most reliable predictors of impending complications. Intense or continuous abdominal pain, particularly when it worsens on palpation, is another red flag that is sometimes underappreciated in busy outpatient settings. Mucosal bleeding, whether from the gums, nose, or in women as abnormal vaginal bleeding, should never be dismissed as minor, even when it appears limited in volume.

Clinicians are also trained to watch for a progressive rise in hematocrit across consecutive readings taken several hours apart, since this reflects ongoing plasma leakage even before the patient looks clinically unwell. Altered mental status, ranging from irritability to drowsiness, and a palpable liver edge more than two centimetres below the costal margin round out the core warning signs that should trigger inpatient evaluation rather than reassurance and discharge.

A subtler but equally important sign is the narrowing of pulse pressure, the gap between systolic and diastolic blood pressure. A narrowing pulse pressure, sometimes to twenty millimetres of mercury or less, can indicate early compensated shock well before systolic blood pressure itself falls, since the body initially compensates through peripheral vasoconstriction.

Diagnosis and Clinical Evaluation

Confirming dengue and assessing its severity relies on a combination of clinical suspicion and targeted laboratory testing rather than any single definitive test performed in isolation. In endemic settings, physicians are encouraged to consider dengue in any acute febrile illness, particularly when accompanied by headache, retro-orbital pain, myalgia, joint pain, or rash.

A complete blood count remains the most practically useful early test. Leukopenia in the early febrile phase raises suspicion for dengue, while a falling platelet count later in the illness course often coincides with the onset of the critical phase. Where available, rapid diagnostic tests for the NS1 antigen can be useful in the first few days of illness, though sensitivity declines after day five and is generally lower in secondary infections, which is precisely the group at higher risk of severe disease. Antibody-based tests become more useful from around day five onward.

Distinguishing dengue from other vector-borne illnesses that circulate in the same season, particularly chikungunya and Zika, adds another layer of diagnostic nuance. Arthralgia is more typical of chikungunya, while pruritus and conjunctivitis lean toward Zika, though overlap is common and laboratory confirmation is often necessary when the distinction changes management.

Ultrasound imaging of the chest and abdomen can help document plasma leakage through the detection of pleural effusion, ascites, or gallbladder wall oedema, and is particularly useful in cases where the clinical picture is ambiguous or where hemoconcentration is masked by concurrent bleeding.

Treatment and Fluid Management Strategies

Fluid management is the single most consequential decision point in dengue shock treatment, and it is also the area where clinical experience has generated the clearest, most consistently validated lessons.

The foundational principle is that fluid replacement should be just adequate, neither too little nor too much. Isotonic crystalloid solutions, such as lactated Ringer's or normal saline, are the preferred first-line fluids. Half normal saline is specifically discouraged in dengue because its lower osmolarity allows it to leak more readily into third spaces, worsening pleural effusion or ascites rather than supporting effective circulating volume.

For patients presenting with compensated shock, meaning narrowed pulse pressure but still measurable blood pressure, an initial crystalloid bolus followed by close reassessment of clinical status, urine output, and hematocrit trend is the standard approach. If the patient does not respond adequately after two to three boluses, colloid solutions may be introduced, though clinicians are cautioned that certain colloids can themselves worsen bleeding tendencies in some patients.

Equally important, and often underemphasised in training, is the deliberate step-down of fluid rates once a patient stabilises. The critical phase of plasma leakage typically resolves within twenty-four to forty-eight hours, after which the leaked fluid begins to resorb back into circulation. Continuing aggressive fluid administration into this resorption phase is a well-documented cause of preventable complications, including pulmonary oedema and respiratory distress. Physicians are advised to reduce infusion rates progressively as clinical parameters improve rather than maintaining a fixed rate out of caution.

Blood product use also deserves careful judgement. Prophylactic platelet transfusion for low platelet counts alone has not been shown to reduce bleeding risk in dengue and is generally discouraged, since it does not address the underlying plasma leakage and may contribute to fluid overload. Packed red blood cells or whole blood transfusion, on the other hand, is appropriate when there is clinically significant bleeding or a falling hematocrit accompanied by unstable vital signs, since restoring oxygen-carrying capacity takes priority in that scenario.

Corticosteroids, once used with some regularity in dengue management in certain settings, are not recommended for routine use, as they have not demonstrated consistent benefit and carry risks including gastrointestinal bleeding and hyperglycaemia.

Monitoring During the Critical Phase

Close, structured monitoring during the critical phase is what allows physicians to catch deterioration early enough to intervene effectively. Vital signs, including heart rate, blood pressure, and respiratory rate, are typically checked every few hours in stable patients and much more frequently, sometimes every fifteen minutes, in those with profound shock. Hematocrit trends, checked before and after fluid boluses and then periodically thereafter, remain one of the most reliable bedside indicators of ongoing plasma leakage or, conversely, of adequate resuscitation.

Urine output monitoring is another practical marker that deserves more consistent attention than it sometimes receives, particularly in adult wards where intake and output charting can be inconsistent. A urine output below roughly half a millilitre per kilogram per hour suggests inadequate perfusion, while output above one and a half millilitres per kilogram per hour once fluids have been reduced may indicate early volume overload.

Training programmes that have been implemented across various dengue endemic regions have consistently shown that structured monitoring protocols, when actually followed at the bedside, correlate with improved outcomes. However, real-world barriers, such as nursing staff shortages, slow laboratory turnaround for hematocrit results, and inconsistent adherence to intake-output charting, frequently limit how well these protocols are executed. Addressing these operational gaps, rather than simply reinforcing the clinical knowledge itself, appears to be where many hospitals see the greatest room for improvement.

Prevention and Proactive Measures

While this article focuses primarily on management once shock develops, prevention of severe outcomes begins well before a patient reaches the critical phase. Patient education at the point of initial diagnosis, including clear guidance on warning signs and the importance of returning to a facility promptly if they appear, has repeatedly been shown to reduce delays in presentation.

For hospitals and clinics, having a written protocol or standing order set for dengue fluid management can reduce variability in care, particularly in high-volume outbreak periods when multiple physicians and shifts are involved in a single patient's care. Several experienced clinicians have specifically noted that standardising fluid protocols, even informally through department-level guidance, reduces the kind of practice variation that otherwise leads to inconsistent outcomes.

At a broader public health level, vector control remains central to reducing dengue incidence altogether. India's National Vector Borne Disease Control Programme continues to coordinate source reduction, larvicidal spraying, and community awareness campaigns, particularly ahead of and during monsoon season when Aedes mosquito breeding conditions are most favourable. Physicians can play a meaningful role here as well, using patient encounters as an opportunity to reinforce basic vector control messaging around eliminating stagnant water and using protective measures at home.

Conclusion

Dengue shock syndrome management rewards vigilance, disciplined fluid titration, and a willingness to reassess frequently rather than follow a fixed protocol regardless of the patient's evolving status. The clinical lessons drawn from decades of experience at high-volume treatment centres are strikingly consistent: recognise the critical phase early, use isotonic fluids judiciously, avoid the twin errors of under-resuscitation and fluid overload, and monitor closely enough to catch deterioration before it becomes irreversible. For physicians across India, particularly those working in settings with variable access to intensive care and rapid diagnostics, internalising these principles and, where possible, embedding them into department-level protocols remains one of the most effective ways to improve outcomes for patients with severe dengue. Platforms like HealthVoice offer physicians a space to discuss exactly these kinds of case-based learnings with peers, share protocol experiences across institutions, and strengthen the collective clinical knowledge that ultimately benefits patient care.

Frequently Asked Questions

Q1: What is the critical phase in dengue shock syndrome?

The critical phase typically begins around the time of defervescence, when the fever subsides, and lasts for twenty-four to forty-eight hours. During this window, plasma leakage occurs, and patients may deteriorate rapidly if not monitored closely.

Q2: Why should corticosteroids not be used routinely in dengue shock?

Corticosteroids have not shown consistent benefit in dengue shock syndrome and may increase risks such as gastrointestinal bleeding, hyperglycaemia, and immunosuppression. Current guidelines do not recommend their routine use.

Q3: What type of intravenous fluid is preferred in dengue shock?

Isotonic crystalloid solutions, such as lactated Ringers or normal saline, are preferred. Hypotonic solutions like half normal saline are avoided because they can worsen fluid accumulation in third spaces such as the pleural or abdominal cavity.

Q4: How is fluid overload avoided during dengue shock treatment?

Physicians titrate fluid volumes based on frequent monitoring of hematocrit, urine output, and vital signs, and reduce the infusion rate progressively once the patient stabilises, since the resorption phase carries its own risk of pulmonary and systemic fluid overload.

Q5: When should platelet transfusion be considered in dengue?

Prophylactic platelet transfusion is generally not recommended, as it has not been shown to reduce bleeding risk. It may be considered selectively in adults with very low platelet counts who have additional bleeding risk factors.

#DengueManagement #MedicalEducation